Vetter’s European clinical site receives permanent Manufacturer’s Authorization
Join our experts for an in-depth look at how injectable drug owners can achieve right-first-time success with their clinical trial materials.
Ongoing investments in the supply chain for complex injectable medications
Identified as best-in-class CDMO in global biopharmaceutical aseptic fill-and-finish services
After a complete revision of the EU GMP Annex 1, the final version was published in August 2022 and became effective just a few days ago on August 25,…
Proven Process to Optimize Commercial Readiness
We just published our annual sustainability report.
John K. Moore, Vetter’s Director of Global Clinical Business Development, shares his biggest takeaways from the event.
Vetter honored as an exceptionally managed company.
Vetter further expands offerings for clinical development and manufacturing.
Vetter honored as winner in all six core award categories.